News from us and our partners

Tags

Topics

0 results

News
9 January, 2024
Pyrowave and University of Sherbrooke target cement decarbonization
News
8 January, 2024
NanoPhoria appoints Dr. Suman Shirodkar as chair and Prof. Michael Davidson as non-executive member of the Board of Directors
News
7 January, 2024
Calliditas Therapeutics appoints Maria Törnsén as President North America
News
4 January, 2024
Inspirna licenses ompenaclid to Merck KGaA
News
4 January, 2024
Sofinnova Partners brings in Dr. Joshua Makower, Stanford Biodesign co-founder, as Venture Partner
News
4 January, 2024
Sitryx announces collaboration partner Lilly has commenced a Phase 1 study of SIT-011 for chronic autoimmune and inflammatory diseases
News
2 January, 2024
NanoPhoria Bioscience publishes groundbreaking study in major cardiology journal
News
21 December, 2023
Sofinnova Partners welcomes Andrew M. Weiss as Venture Partner
News
20 December, 2023
Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function
News
18 December, 2023
Industry veteran Abbas Hussain appointed as Chair of Asceneuron
News
14 December, 2023
Mission Therapeutics wins FDA IND approval for MTX652 in AKI
News
13 December, 2023
Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France
News
13 December, 2023
Sofinnova Partners launches Biovelocita, the first Pan-European investment strategy dedicated to the creation and acceleration of biotech startups
News
12 December, 2023
Freya Biosciences raises $38M Series A for women's fertility
News
11 December, 2023
Pi-Cardia hires Gary Gratson to lead global commercialization
News
6 December, 2023
Crescendo Biologics doses first US patients in CB307 Phase 1b trial

Pyrowave and University of Sherbrooke target cement decarbonization

NanoPhoria appoints Dr. Suman Shirodkar as chair and Prof. Michael Davidson as non-executive member of the Board of Directors

Calliditas Therapeutics appoints Maria Törnsén as President North America

Inspirna licenses ompenaclid to Merck KGaA

Sofinnova Partners brings in Dr. Joshua Makower, Stanford Biodesign co-founder, as Venture Partner

Sitryx announces collaboration partner Lilly has commenced a Phase 1 study of SIT-011 for chronic autoimmune and inflammatory diseases

NanoPhoria Bioscience publishes groundbreaking study in major cardiology journal

Sofinnova Partners welcomes Andrew M. Weiss as Venture Partner

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

Industry veteran Abbas Hussain appointed as Chair of Asceneuron

Mission Therapeutics wins FDA IND approval for MTX652 in AKI

Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France

Sofinnova Partners launches Biovelocita, the first Pan-European investment strategy dedicated to the creation and acceleration of biotech startups

Freya Biosciences raises $38M Series A for women's fertility

Pi-Cardia hires Gary Gratson to lead global commercialization

Crescendo Biologics doses first US patients in CB307 Phase 1b trial